Dr. Jeffrey Warren Allen, MD

Dr. Allen practices at Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health.

Dr. Allen's NPI, 1104040104, was assigned on April 12, 2007. Dr. Allen graduated from Albany Medical College of Union University in 2002. Dr. Allen holds Idaho license M12843.

Dr. Allen's primary practice is Kootenai Health, at 2003 Kootenai Health Way, Coeur D Alene, ID 83814 in Kootenai County. The practice phone is (208) 625-4000.

Dr. Allen's primary practice is Kootenai Health in Coeur D Alene, Idaho, part of Kootenai Health. Dr. Allen is also affiliated with Norton Hospital. The medical group on file is Kootenai Health. Dmand AI also links Dr. Allen to 3 more hospitals, 2 group practices and clinics, 1 hospital outpatient department and 1 medical group, each named with a free account. Dr. Allen's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Allen practices, 8 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Allen's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Allen is board certified in hematology by the American Board of Internal Medicine. Dr. Allen is licensed in Idaho.

CMS data shows 2,098 Medicare services from Dr. Allen across 10 procedure codes in 2024, for 510 Medicare patients. Medicare paid $111,624 for them.

CMS counts 510 Medicare patients who saw Dr. Allen in 2024. The largest group is 65 to 74, with 227 patients. 71% of them have high blood pressure, and 58% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Allen's median patient age at 75, with 60% women.

In 2024, Dr. Allen wrote 2,661 Medicare Part D claims for 376 patients. 68% of them were for generic drugs. CMS names the drug for 2,188 of them, across 50 drugs with 11 or more claims each, at $6,596,447 in total drug cost. In 2023, CMS named 2,146 claims across 54 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Allen for performance year 2024, reported through an alternative payment model (APM). Dr. Allen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Allen as offering telehealth.

CMS Open Payments shows 44 general payments to Dr. Allen from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. Eli Lilly and Company paid the most, $2,529.

Dr. Allen graduated from Albany Medical College of Union University in 2002.